Prognostic Risk Profiling from Digitized H&E

Take a look at new international performances of RlapsRisk BC

See how AI is challenging traditional breast cancer prognostic testing— from routine H&E slides.

Watch the Head of the Pathology Lab at Gustave Roussy, Dr. Magali Lacroix-Triki, and Owkin Senior Data Scientist, Valentin Guary, reveal how RlapsRisk BC performs against molecular tests and clinical scores. Get the latest international data, real-world implementation insights, and discover what this means for treatment decisions. Perfect for pathologists, oncologists, and precision medicine innovators. Access the replay now